aTYR PHARMA (ATYR) Income from Non-Controlling Interests (2020 - 2026)
aTYR PHARMA (ATYR) recorded Income from Non-Controlling Interests of -$1,000 in Q2 2026, compared with -$1,000 a year earlier.
Powered by 
Analysis
aTYR PHARMA (ATYR) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends
On a TTM basis, aTYR PHARMA's Income from Non-Controlling Interests came in at -$5,000 as of Jun 30, 2026; for FY2025, it came in at -$5,000.
- Across earlier years, Income from Non-Controlling Interests came in at $1,000 in FY2024, -$8,000 in FY2023, -$5,000 in FY2022 and -$9,000 in FY2021.
- Quarterly Income from Non-Controlling Interests has ranged from -$4,000 in Q2 2023 to $4,000 in Q1 2024 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$1,000 (Q1 2026), -$1,000 (Q4 2025) and -$2,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | - |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 10.00 Mn |
| 10 | aTYR PHARMA | 16.67 Mn | -276.34 Mn | - | -1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -4,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | -2,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Jun 30, 2021 | -1,000.00 |
API Access
aTYR PHARMA Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ATYR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "ATYR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ATYR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();